Thermo Fisher击败了收入估计,提出了2025年的指导意见,并宣布了红利和回购。 Thermo Fisher beat earnings estimates, raised 2025 guidance, and announced a dividend and buyback.

Thermo Fisher科学公司(TMO)于10月22日报告Q3收入丰厚, 比估计数高出5.79 EPS-0.29美元,收入11.12亿美元,比年增长4.9%。 Thermo Fisher Scientific Inc. (TMO) reported strong Q3 earnings on October 22, posting $5.79 EPS—$0.29 above estimates—with $11.12 billion in revenue, a 4.9% year-over-year increase. 该公司将其2025年财政EPS指南提高到22.60至22.86美元,并宣布季度红利为0.43美元,股票回购计划。 The company raised its fiscal 2025 EPS guidance to $22.60–$22.86 and announced a $0.43 quarterly dividend and a share repurchase program. 机构投资者,包括United Super Pty Ltd, J.W. Institutional investors, including United Super Pty Ltd, J.W. Cole顾问和Findlay Park Partners LLP调整了他们的股份,而内幕人员出售了52 570股股份。 Cole Advisors, and Findlay Park Partners LLP, adjusted their stakes, while insiders sold a combined 52,570 shares. 股票交易额为593.41美元,市场上限为2229.5亿美元,P/E比率为34.28,协商一致价格目标为601.65美元。 The stock trades at $593.41 with a market cap of $222.95 billion, a P/E ratio of 34.28, and a consensus price target of $601.65.